Thrivent Financial for Lutherans Purchases 5,835 Shares of Sotera Health (NASDAQ:SHC)

Thrivent Financial for Lutherans raised its position in Sotera Health (NASDAQ:SHC) by 19.4% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 35,929 shares of the company’s stock after acquiring an additional 5,835 shares during the period. Thrivent Financial for Lutherans’ holdings in Sotera Health were worth $600,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently bought and sold shares of the company. Sessa Capital IM L.P. increased its holdings in shares of Sotera Health by 7.5% during the 2nd quarter. Sessa Capital IM L.P. now owns 4,300,597 shares of the company’s stock worth $51,048,000 after acquiring an additional 300,597 shares during the last quarter. Darsana Capital Partners LP acquired a new position in shares of Sotera Health during the 2nd quarter worth approximately $29,074,000. William Blair Investment Management LLC increased its holdings in shares of Sotera Health by 0.6% during the 2nd quarter. William Blair Investment Management LLC now owns 1,131,455 shares of the company’s stock worth $13,430,000 after acquiring an additional 6,707 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Sotera Health by 3.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,004,046 shares of the company’s stock worth $11,918,000 after acquiring an additional 37,681 shares during the last quarter. Finally, AQR Capital Management LLC increased its holdings in shares of Sotera Health by 3,198.2% during the 2nd quarter. AQR Capital Management LLC now owns 511,580 shares of the company’s stock worth $6,072,000 after acquiring an additional 496,069 shares during the last quarter. Institutional investors own 91.03% of the company’s stock.

Sotera Health Stock Up 3.5 %

SHC stock opened at $13.28 on Thursday. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.44. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. The stock’s 50 day moving average is $15.04 and its 200-day moving average is $14.06. The firm has a market capitalization of $3.76 billion, a PE ratio of 53.12 and a beta of 1.96.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). The business had revenue of $285.47 million for the quarter, compared to the consensus estimate of $278.64 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The business’s revenue was up 8.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.18 earnings per share. Sell-side analysts expect that Sotera Health will post 0.61 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

SHC has been the topic of a number of research reports. Citigroup upped their price objective on Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a report on Wednesday, November 6th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $17.00 price objective on shares of Sotera Health in a report on Thursday, November 21st. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, Sotera Health presently has an average rating of “Moderate Buy” and an average target price of $16.50.

Insider Buying and Selling at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the transaction, the director now owns 49,215,301 shares in the company, valued at approximately $739,705,974.03. This represents a 16.89 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 55.12% of the stock is currently owned by corporate insiders.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.